(74 \ m=+-\4 vs 97 \ m=+-\8 \g=m\mol/l),triglyceride (0.69 \ m=+-\0.04 vs 1.02 \m=+-\0.17mmol/l) and diastolic blood pressure (77 \m=+-\3 vs 90 \m=+-\10 mmHg) levels. The rate of insulinmediated glucose metabolism (1 mU euglycaemic insulin clamp) was virtually identical in each diabetic group (4.80 \ m=+-\ 0.42, 4.90 \ m=+-\ 0.36 and 4.98 \ m=+-\ 0.74 mg/kg/min) and 40% below that in 8 matched normal subjects (7.53 \ m=+-\0.53 mg/kg/min, P < 0.001).
In conclusion, proliferative retinopathy is related to long duration of diabetes, incipient nephropathy and hypertension. Insulin resistance characterizes the majority of patients with type 1 diabetes but is unrelated to retinopathy.
Retinopathy is a common complication in type 1 diabetes. After 20 years of the disease, retinopa¬ thy of varying degrees occurs in more than 90% of the patients (Klein et al. 1984a,b (Skyler 1979 (Barbosa & Saner 1984) , smoking (Paetkau et al. 1977) , alcohol consumption (Young et al. 1984) (Table 3) .
Compared with the normal subjects, the rate of glucose metabolism was significantly reduced (P < 0.001) in all diabetic groups (Fig. 1) . The mean reduction (40%) and the within-group variation in insulin sensitivity were similar in the diabetic groups and thus no relationship was found between severity of retinopathy and insulin sensitivity. Also, no significant relationships were found between age, relative body weight, glycaemic control, C-peptide or insulin dose (U/day or U/kg) and insulin sensitivity. (Maneschi et al. 1983 ). This difference is probably related to the patient population studied rather than the methodology employed since a similar insulin clamp technique was used in both studies.
Our failure to find any association between re¬ tinopathy and insulin resistance cannot be attri¬ buted to the size of the study population since the number of patients studied was higher than in that of Maneschi et al. (1983 
